A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis

Published:2014-07-09 Issue:7 Volume:19 Page:1013-1018
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Chambers Daniel C.¹²,Enever Debra¹,Ilic Nina³,Sparks Lisa⁴,Whitelaw Kylie¹,Ayres John⁵,Yerkovich Stephanie T.¹²,Khalil Dalia⁶,Atkinson Kerry M.⁷⁸,Hopkins Peter M.A.¹²

Affiliation:

1. Queensland Lung Transplant Service; The Prince Charles Hospital

2. School of Medicine; The University of Queensland; Brisbane Queensland Australia

3. Mater Health Services; Brisbane Queensland Australia

4. Queensland Heart Valve Bank; The Prince Charles Hospital; Brisbane Queensland Australia

5. Department of Radiology; The Prince Charles Hospital; Brisbane Queensland Australia

6. Mater Research Institute; Brisbane Queensland Australia

7. University of Queensland Centre for Clinical Research, RBWH Campus; Brisbane Queensland Australia

8. Stem Cell Therapies Laboratory, Queensland Institute of Technology; Translational Research Institute; Brisbane Queensland Australia

Funder

Perpetual FoundationThe Ann Helene Toakley Charitable Endowment

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12343/fullpdf

Reference29 articles.

1. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis;Faner;Am. J. Respir. Crit. Care Med.,2012

2. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis;Sisson;Am. J. Respir. Crit. Care Med.,2010

3. Lung fibrosis, premature graying, and macrocytosis;Chambers;Am. J. Respir. Crit. Care Med.,2012

4. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator;Jarvinen;J. Immunol.,2008

5. Mesenchymal stem cells and the lung;Sinclair;Respirology,2013

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

3. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18

4. Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells;Cells;2024-05-22

5. Therapeutic Strategies for Idiopathic Pulmonary Fibrosis – Thriving Present and Promising Tomorrow;The Journal of Clinical Pharmacology;2024-02-12